EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structural basis for a p21-activated kinase 4 and nicotinamide phosphoribosyltransferase dual inhibitor

Jaehui Park iD, Hye Rim Hong, Sang Hyun Han, Jinsue Song, Se Young Son, Saehae Choi, Sang Mi Park, Won Kyu Lee iD, Chimari Jiko iD, Ji Hun Kim, Jun Goo Jee, Jeong Kyu Bang und 2 weitere

Acta Crystallographica Section D Structural Biology · 01.08.2026 · 82 (8) · 972-981

DOI: 10.1107/s2059798326006145 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Crystallographica Section D Structural Biology, online erschienen am 20.07.2026. Verfasst von Jaehui Park und 13 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Chungbuk National University, Chungbuk 28160, South Korea. Hauptthemen laut MEDLINE: Nicotinamide Phosphoribosyltransferase, p21-Activated Kinases, Aminopyridines, Acrylamides. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Chungbuk National University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Simultaneous inhibition of oncogenic signaling and metabolic pathways represents a promising approach for cancer therapy. KPT-9274, a clinical stage compound, has been reported as a dual inhibitor of p21-activated kinase 4 (PAK4) and nicotinamide phosphoribosyltransferase (NAMPT), but its structural basis has remained undefined. Here, we present high-resolution crystal structures of PAK4 and NAMPT in complex with KPT-7523, an analog of KPT-9274, determined at 2.20 and 1.45 Å resolution, respectively. In PAK4, the 2-aminopyridine moiety of KPT-7523 enables dual binding, occupying the adenine-binding site for ATP and simultaneously engaging the substrate-binding cleft in the C-lobe, thereby interfering with both catalytic and regulatory functions. In NAMPT, the same scaffold inserts into the NAD + active site in an extended conformation that preserves critical interactions. Biophysical assays revealed distinct affinities across the two targets. These findings highlight the 2-aminopyridine moiety as a versatile pharmacophore that is adaptable to structurally unrelated proteins and provide a framework for designing next-generation dual inhibitors in cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nicotinamide Phosphoribosyltransferasep21-Activated KinasesAminopyridinesAcrylamidesEnzyme InhibitorsCytokinesProtein Kinase InhibitorsHumansCrystallography, X-RayModels, MolecularCatalytic Domain

Stichwörter der Autor:innen

2-aminopyridine pharmacophoreKPT-7523NAMPTPAK4dual inhibition

Substanzen

Nicotinamide Phosphoribosyltransferasep21-Activated KinasesPAK4 protein, humanKPT-9274AminopyridinesAcrylamidesEnzyme InhibitorsCytokinesnicotinamide phosphoribosyltransferase, humanProtein Kinase Inhibitors

Autor:innen und Institutionen

  • College of Pharmacy, Chungbuk National University, Chungbuk 28160, South Korea.
  • New Drug Development Center, Osong Medical Innovation Foundation, Osong Cheongju, Chungbuk 28160, South Korea.
  • Clinical Research Center, Masan National Tuberculosis Hospital, Changwon 51755, South Korea.
  • Division of Radiation Life Science, Institute for Integrated Radiation and Nuclear Science, Kyoto University, Osaka, Japan.
  • Research Institute of Pharmaceutical Researches, College of Pharmacy, Kyungpook National University, Daegu 41566, South Korea.
  • Division of Magnetic Resonance, Korea Basic Science Institute (KBSI), Ochang, Chungbuk 28119, South Korea.

ORCID-Profile: Jaehui Park, Won Kyu Lee, Chimari Jiko, Il Yeong Park, Soo Jae Lee

Förderung

  • Ministry of Education
  • Chungbuk National University

Zitieren

APA

Park, J., Hong, H. R., Han, S. H., Song, J., Son, S. Y., Choi, S., Park, S. M., Lee, W. K., Jiko, C., Kim, J. H., Jee, J. G., Bang, J. K., Park, I. Y., & Lee, S. J. (2026). Structural basis for a p21-activated kinase 4 and nicotinamide phosphoribosyltransferase dual inhibitor. Acta Crystallographica Section D Structural Biology, 82(8), 972-981. https://doi.org/10.1107/s2059798326006145

Vancouver

Park J, Hong HR, Han SH, Song J, Son SY, Choi S, et al. Structural basis for a p21-activated kinase 4 and nicotinamide phosphoribosyltransferase dual inhibitor. Acta Crystallographica Section D Structural Biology. 2026;82(8):972-981. doi:10.1107/s2059798326006145

BibTeX
@article{Park2026,
  author = {Park, Jaehui and Hong, Hye Rim and Han, Sang Hyun and Song, Jinsue and Son, Se Young and Choi, Saehae and Park, Sang Mi and Lee, Won Kyu and Jiko, Chimari and Kim, Ji Hun and Jee, Jun Goo and Bang, Jeong Kyu and Park, Il Yeong and Lee, Soo Jae},
  title = {Structural basis for a p21-activated kinase 4 and nicotinamide phosphoribosyltransferase dual inhibitor},
  journal = {Acta Crystallographica Section D Structural Biology},
  year = {2026},
  volume = {82},
  number = {8},
  pages = {972--981},
  doi = {10.1107/s2059798326006145}
}
Kostenlos starten →